514 related articles for article (PubMed ID: 12645951)
21. Complement regulatory proteins in normal human esophagus and esophageal squamous cell carcinoma.
Shimo K; Mizuno M; Nasu J; Hiraoka S; Makidono C; Okazaki H; Yamamoto K; Okada H; Fujita T; Shiratori Y
J Gastroenterol Hepatol; 2004 Jun; 19(6):643-7. PubMed ID: 15151618
[TBL] [Abstract][Full Text] [Related]
22. A bispecific monoclonal antibody directed against both the membrane-bound complement regulator CD55 and the renal tumor-associated antigen G250 enhances C3 deposition and tumor cell lysis by complement.
Blok VT; Daha MR; Tijsma O; Harris CL; Morgan BP; Fleuren GJ; Gorter A
J Immunol; 1998 Apr; 160(7):3437-43. PubMed ID: 9531304
[TBL] [Abstract][Full Text] [Related]
23. Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59.
Schmitz J; Zimmer JP; Kluxen B; Aries S; Bögel M; Gigli I; Schmitz H
J Clin Invest; 1995 Sep; 96(3):1520-6. PubMed ID: 7544808
[TBL] [Abstract][Full Text] [Related]
24. Cell-surface density of complement restriction factors (CD46, CD55, and CD59): oral squamous cell carcinoma versus other solid tumors.
Ravindranath NM; Shuler C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb; 103(2):231-9. PubMed ID: 17234541
[TBL] [Abstract][Full Text] [Related]
25. Effect of transfected MACIF (CD59) on complement-mediated swine endothelial cell lysis, compared with those of membrane cofactor protein (CD46) and decay-accelerating factor (CD55).
Miyagawa S; Shirakura R; Nakata S; Izutani H; Matsuda H; Iwata K; Nagasawa S; Terado A; Hatanaka M; Matsumoto M
Transplant Proc; 1995 Feb; 27(1):328-9. PubMed ID: 7533401
[No Abstract] [Full Text] [Related]
26. Complement regulatory proteins in the salivary glands and saliva of Sjögren's syndrome patients and healthy subjects.
Cuida M; Legler DW; Eidsheim M; Jonsson R
Clin Exp Rheumatol; 1997; 15(6):615-23. PubMed ID: 9444417
[TBL] [Abstract][Full Text] [Related]
27. Effect of glycosylphosphatidylinositol specific phospholipase D gene expression levels on complement mediated killing of leukemic cells in patients with chronic myeloid leukemia.
Jian-Hua T; Xiao-Jie Z; Yi-Dan W; Wen-Kai L; Wang-Jiao H; Cheng-Hong W; Gui-Yuan L
Clin Chim Acta; 2005 Sep; 359(1-2):115-24. PubMed ID: 15907827
[TBL] [Abstract][Full Text] [Related]
28. Glucose-induced loss of glycosyl-phosphatidylinositol-anchored membrane regulators of complement activation (CD59, CD55) by in vitro cultured human umbilical vein endothelial cells.
Accardo-Palumbo A; Triolo G; Colonna-Romano G; Potestio M; Carbone M; Ferrante A; Giardina E; Caimi G; Triolo G
Diabetologia; 2000 Aug; 43(8):1039-47. PubMed ID: 10990082
[TBL] [Abstract][Full Text] [Related]
29. Levels of expression of complement regulatory proteins CD46, CD55 and CD59 on resting and activated human peripheral blood leucocytes.
Christmas SE; de la Mata Espinosa CT; Halliday D; Buxton CA; Cummerson JA; Johnson PM
Immunology; 2006 Dec; 119(4):522-8. PubMed ID: 16999828
[TBL] [Abstract][Full Text] [Related]
30. Adenovirus-mediated expression of human CD55 or CD59 protects adult porcine islets from complement-mediated cell lysis by human serum.
Schmidt P; Goto M; Le Mauff B; Anegon I; Korsgren O
Transplantation; 2003 Mar; 75(5):697-702. PubMed ID: 12640312
[TBL] [Abstract][Full Text] [Related]
31. [The role of membrane glycoproteins CD46, CD55 and CD59 in protection of tumor cells against complement lysis].
Wojnicz D; Bar J; Jankowski S
Postepy Hig Med Dosw; 2002; 56(5):603-16. PubMed ID: 12587428
[TBL] [Abstract][Full Text] [Related]
32. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
[TBL] [Abstract][Full Text] [Related]
33. Expression of membrane complement regulators, CD46, CD55 and CD59, in mesothelial cells of patients on peritoneal dialysis therapy.
Sei Y; Mizuno M; Suzuki Y; Imai M; Higashide K; Harris CL; Sakata F; Iguchi D; Fujiwara M; Kodera Y; Maruyama S; Matsuo S; Ito Y
Mol Immunol; 2015 Jun; 65(2):302-9. PubMed ID: 25725314
[TBL] [Abstract][Full Text] [Related]
34. CD59 expressed on a tumor cell surface modulates decay-accelerating factor expression and enhances tumor growth in a rat model of human neuroblastoma.
Chen S; Caragine T; Cheung NK; Tomlinson S
Cancer Res; 2000 Jun; 60(11):3013-8. PubMed ID: 10850450
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a glycosyl-phosphatidylinositol anchor-deficient subline of Raji cells. An analysis of the functional importance of complement inhibitors on the Raji cell line.
Harris CL; Morgan BP
Immunology; 1995 Oct; 86(2):311-8. PubMed ID: 7490134
[TBL] [Abstract][Full Text] [Related]
36. Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma.
Macor P; Mezzanzanica D; Cossetti C; Alberti P; Figini M; Canevari S; Tedesco F
Cancer Res; 2006 Apr; 66(7):3876-83. PubMed ID: 16585216
[TBL] [Abstract][Full Text] [Related]
37. Expression of complement regulatory proteins on human natural killer cell subsets.
Wang L; Halliday D; Johnson PM; Christmas SE
Immunol Lett; 2007 Oct; 112(2):104-9. PubMed ID: 17719652
[TBL] [Abstract][Full Text] [Related]
38. B lymphocytes and macrophages release cell membrane deposited C3-fragments on exosomes with T cell response-enhancing capacity.
Papp K; Végh P; Prechl J; Kerekes K; Kovács J; Csikós G; Bajtay Z; Erdei A
Mol Immunol; 2008 Apr; 45(8):2343-51. PubMed ID: 18192019
[TBL] [Abstract][Full Text] [Related]
39. Adeno-associated virus mediated delivery of an engineered protein that combines the complement inhibitory properties of CD46, CD55 and CD59.
Leaderer D; Cashman SM; Kumar-Singh R
J Gene Med; 2015; 17(6-7):101-15. PubMed ID: 25917932
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo.
Sullivan BL; Knopoff EJ; Saifuddin M; Takefman DM; Saarloos MN; Sha BE; Spear GT
J Immunol; 1996 Aug; 157(4):1791-8. PubMed ID: 8759769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]